Cantourage Group SE (HAM:HIGH) EPS without NRI: €0.00 (TTM As of Jun. 2025)


HAM:HIGH Cantourage Group SE HAM:HIGH
20 GF Score
Price €5.82
! 4 Warning Signs
View Full Analysis

What is Cantourage Group SE EPS without NRI?

Cantourage Group SE HAM:HIGH -5.83% 20 EPS without NRI is €0.00 as of Jun. 2025. GuruFocus rates HAM:HIGH with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 787 Drug Manufacturers companies, Cantourage Group SE ranks worse than 98.48% on this metric.

Cantourage Group SE's earnings per share without non-recurring items for the six months ended in Jun. 2025 was €0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2025 was €0.00.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -94.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Cantourage Group SE's EPS without NRI or its related term are showing as below:

HAM:HIGH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -94   Med: -94   Max: -94
Current: -94

During the past 5 years, Cantourage Group SE's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -94.00% per year. The lowest was -94.00% per year. And the median was -94.00% per year.

HAM:HIGH's 3-Year EPS without NRI Growth Rate is ranked worse than
98.48% of 787 companies
in the Drug Manufacturers industry
Industry Median: 9.7 vs HAM:HIGH: -94.00

Cantourage Group SE's EPS (Diluted) for the six months ended in Jun. 2025 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was €0.00.

Cantourage Group SE's EPS (Basic) for the six months ended in Jun. 2025 was €0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2025 was €0.00.


Cantourage Group SE  (HAM:HIGH) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cantourage Group SE EPS without NRI Related Terms


Cantourage Group SE EPS without NRI Historical Data

* Premium members only.

The historical data trend for Cantourage Group SE's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE EPS without NRI Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
-0.01 -0.05 -0.08 0.00 -0.34

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25
EPS without NRI Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -0.35 0.02 0.00

HAM:HIGH vs ZTS, UTHR, VTRS: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's PE Ratio without NRI falls into.


HAM:HIGH
20GF Score
Cantourage Group SE HAM:HIGH
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantourage Group SE EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €0.00 mean?
Cantourage Group SE (HAM:HIGH) has a EPS without NRI of €0.00 as of Jun. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cantourage Group SE and its competitors. According to the industry distribution chart, Cantourage Group SE ranks #775 out of 787 companies in the Drug Manufacturers industry, placing it in the top 98.5%.
Is Cantourage Group SE's EPS without NRI too high?
Cantourage Group SE's current EPS without NRI is €0.00. Based on the distribution chart, Cantourage Group SE ranks #775 out of 787 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cantourage Group SE has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's EPS without NRI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cantourage Group SE ranks #775 out of 787 companies for EPS without NRI. This places Cantourage Group SE in the lower half of its industry. The industry median EPS without NRI is 9.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.70, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cantourage Group SE and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantourage Group SE's current EPS without NRI is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (HAM:HIGH) has a current EPS without NRI of €0.00. The current EPS without NRI is €0.00. Cantourage Group SE's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Cantourage Group SE (HAM:HIGH), the current EPS without NRI is €0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantourage Group SE Business Description

Other Exchanges HIGH:Germany
Address Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
20GF Score

Get the complete analysis for HAM:HIGH

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.82
Price